Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
FerroptoCure Inc. logo — Ferroptosis to Cure

FerroptoCure Inc.

Ferroptosis to Cure

Founded 2022 Japan Japan 2 employees Seed Total: $3.00M

General Information

Company Name FerroptoCure Inc.
Founded Year 2022
Location Japan Japan
Employees 2
Funding Stage Seed
Business Model B2B, B2D
Revenue Model Licensing, Product Sales, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with FerroptoCure Inc.. To contact FerroptoCure Inc., visit ferroptocure.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does FerroptoCure Inc. compare?

A PDF of FerroptoCure Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting FerroptoCure Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About FerroptoCure Inc.

FerroptoCure Inc., founded in 2022 and headquartered in Japan, is a promising player in the oncology sector. The company operates under the slogan "Ferroptosis to Cure", leveraging a novel approach targeting ferroptosis, a cell death mechanism disrupted in cancer cells by oxidative stress resistance.

FerroptoCure’s innovative drugs address this pathway, aiming to overcome cancer cells' resistance to ferroptosis. Successfully targeting this mechanism could yield therapeutic solutions for various cancer types. The company has already advanced its drug candidates to Phase I clinical trials, marking a significant milestone in their development process.

In September 2025, the company secured a $3.00M grant investment from a consortium of investors including ANRI, Japan Science and Technology Agency, Tokyo University of Science Innovation Capital, Diamond Medino Capital, and Vision Incubate. This financial backing underscores investor confidence in FerroptoCure’s potential to innovate in the cancer treatment landscape.

Business keywords: cancer treatment, ferroptosis, oxidative stress, drug development, oncology, pharmaceutical innovation, cancer drug resistance, Phase I clinical trials, targeted therapies, cell death mechanisms, R&D in cancer, therapeutic innovation, clinical trials

Services & Products

Research in ferroptosis
Drug pipeline development
Scientific publications
Corporate partnerships

Target Customers

Healthcare institutions Pharma companies Research organizations Medical professionals

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $3.00M 5
ANRI
ANRI, Japan Science and Technology Agency +3
01 Sep 2025

FerroptoCure Inc. Alternatives & Competitors

View All Alternatives
FerroptoCure Inc. vs
BeyondSpring
BeyondSpring United States

Based in Duncan, South Carolina, we are a pioneering biotechnology company dedicated to advancing he...

Series A
51 employees
Biopharma, Health Care
FerroptoCure Inc. vs
Blueprint Medicines
Blueprint Medicines United States

Striving to improve and extend patients' lives

Acquired
782 employees
Biotechnology, Health Care
FerroptoCure Inc. vs
Arno Therapeutics Inc (ARNI)
Arno Therapeutics Inc (ARNI)

Arno Therapeutics Inc (ARNI) is a pharmaceuticals company based out of Parsippany, NJ, United States...

Post-IPO Equity
3 employees
Biopharma, Biotechnology
View all alternatives

FAQ About FerroptoCure Inc.

Ferroptosis to Cure
FerroptoCure Inc. was founded in 2022.
FerroptoCure Inc. is headquartered in Japan.
FerroptoCure Inc. has a B2B and B2D business model. Its revenue comes from Licensing, Product Sales and Service Fee.
FerroptoCure Inc. has approximately 2 employees.
FerroptoCure Inc. has completed 1 funding round, raising a total of $3.00M. The latest funding stage is Seed.
FerroptoCure Inc. offers: Research in ferroptosis, Drug pipeline development, Scientific publications, Corporate partnerships.
Top alternatives and competitors to FerroptoCure Inc. include BeyondSpring, Blueprint Medicines, Arno Therapeutics Inc (ARNI), Cavion, Arcellx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
FerroptoCure Inc. and BeyondSpring are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for FerroptoCure Inc., https://bouncewatch.com/company/ferroptocure-inc, updated 13 November 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout